Susquehanna International Group, LLP Kamada LTD Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Kamada LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 21,000 shares of KMDA stock, worth $141,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,000
Previous 14,100
48.94%
Holding current value
$141,330
Previous $93,000
74.19%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding KMDA
# of Institutions
42Shares Held
5.82MCall Options Held
21KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.1 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$5.6 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA610KShares$4.11 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.22 Million0.18% of portfolio
-
Essex Investment Management CO LLC Boston, MA324KShares$2.18 Million0.52% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $302M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...